ToxSci Advance Access published online on July 27, 2005
Toxicological Sciences, doi:10.1093/toxsci/kfi266
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Professor and Chair, Pathology and Microbiology, Havlik-Wall Professor of Oncology, University of Nebraska Medical Center, Department of Pathology and Microbiology, 983135 Nebraska Medical Center, Omaha, NE 68198-3135, 402-559-6388 • Fax 402-559-9297
* To whom correspondence should be addressed.
Received June 16, 2005
Accepted July 20, 2005
Forum
Effects of PPAR
and Combined Agonists on the Urinary Tract of Rats and Other Species
Samuel M. Cohen, E-mail: scohen{at}unmc.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. G. Long, V. L. Reynolds, L. W. Dochterman, and T. E. Ryan Neoplastic and Non-neoplastic Changes in F-344 Rats Treated with Naveglitazar, a {gamma}-Dominant PPAR {alpha}/{gamma} Agonist Toxicol Pathol, October 1, 2009; 37(6): 741 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Tannehill-Gregg, M. A. Dominick, A. J. Reisinger, J. D. Moehlenkamp, C. R. Waites, D. A. Stock, T. P. Sanderson, S. M. Cohen, L. L. Arnold, and B. E. Schilling Strain-related Differences in Urine Composition of Male Rats of Potential Relevance to Urolithiasis Toxicol Pathol, April 1, 2009; 37(3): 293 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Hardisty, D. C. Anderson, S. Brodie, J. M. Cline, F. F. Hahn, H. Kolenda-Roberts, S. M. Lele, and L. J. Lowenstine Histopathology of the Urinary Bladders of Cynomolgus Monkeys Treated with PPAR Agonists Toxicol Pathol, October 1, 2008; 36(6): 769 - 776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Chopra, J. Hinley, M. B. Oleksiewicz, and J. Southgate Trans-Species Comparison of PPAR and RXR Expression by Rat and Human Urothelial Tissues Toxicol Pathol, April 1, 2008; 36(3): 485 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Long, V. L. Reynolds, A. Lopez-Martinez, T. E. Ryan, S. L. White, and S. R. Eldridge Urothelial Carcinogenesis in the Urinary Bladder of Rats Treated with Naveglitazar, a {gamma}-dominant PPAR {alpha}/{gamma} Agonist: Lack of Evidence for Urolithiasis as an Inciting Event Toxicol Pathol, February 1, 2008; 36(2): 218 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ohnishi, L. L. Arnold, N. M. Clark, J. L. Wisecarver, and S. M. Cohen Comparison of Endothelial Cell Proliferation in Normal Liver and Adipose Tissue in B6C3F1 Mice, F344 Rats, and Humans Toxicol Pathol, December 1, 2007; 35(7): 904 - 909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hellmold, H. Zhang, U. Andersson, B. Blomgren, T. Holland, A.-L. Berg, M. Elebring, N. Sjogren, K. Bamberg, B. Dahl, et al. Tesaglitazar, a PPAR{alpha}/{gamma} Agonist, Induces Interstitial Mesenchymal Cell DNA Synthesis and Fibrosarcomas in Subcutaneous Tissues in Rats Toxicol. Sci., July 1, 2007; 98(1): 63 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Tannehill-Gregg, T. P. Sanderson, D. Minnema, R. Voelker, B. Ulland, S. M. Cohen, L. L. Arnold, B. E. Schilling, C. R. Waites, and M. A. Dominick Rodent Carcinogenicity Profile of the Antidiabetic Dual PPAR {alpha} and {gamma} Agonist Muraglitazar Toxicol. Sci., July 1, 2007; 98(1): 258 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Van Vleet, M. R. White, T. P. Sanderson, S. M. Cohen, M. Cano, L. L. Arnold, C. R. Waites, B. E. Schilling, J. Mitroka, and M. A. Dominick Subchronic Urinary Bladder Effects of Muraglitazar in Male Rats Toxicol. Sci., March 1, 2007; 96(1): 58 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Dominick, M. R. White, T. P. Sanderson, T. van Vleet, S. M. Cohen, L. E. Arnold, M. Cano, S. Tannehill-Gregg, J. D. Moehlenkamp, C. R. Waites, et al. Urothelial Carcinogenesis in the Urinary Bladder of Male Rats Treated with Muraglitazar, a PPAR{alpha}/{gamma} Agonist: Evidence for Urolithiasis as the Inciting Event in the Mode of Action Toxicol Pathol, December 1, 2006; 34(7): 903 - 920. [Abstract] [Full Text] [PDF]
|
|